Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2027 - ResearchAndMarkets.com

November 30, 2018

DUBLIN--(BUSINESS WIRE)--Nov 30, 2018--The “Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Nuclear Medicine Market is poised to grow strong during the forecast period 2017 to 2027.Some of the prominent trends that the market is witnessing include increasing incidents of cancer and cardiac ailments, increasing SPECT and PET applications, growing public awareness for healthcare.This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.The study focuses on market trends, leading players, supply chain trends,technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Report Highlights

The report provides a detailed analysis on current and future market trends to identify the investment opportunitiesMarket forecasts till 2027, using estimated market values as the base numbersKey market trends across the business segments, Regions and CountriesKey developments and strategies observed in the marketMarket Dynamics such as Drivers, Restraints, Opportunities and other trendsIn-depth company profiles of key players and upcoming prominent playersGrowth prospects among the emerging nations through 2027Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline

1.1 Research Methodology

1.1.1 Research Approach & Sources

1.2 Market Trends

1.3 Regulatory Factors

1.4 Product Analysis

1.5 Application Analysis

1.6 Strategic Benchmarking

1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Increasing Incidents of Cancer and Cardiac Ailments

3.1.2 Increasing Spect Radiopharmaceuticals and Pet Radiopharmaceuticals Applications

3.1.3 Growing Public Awareness for Healthcare

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Nuclear Medicine Market, By Product

4.1 Therapeutic Products

4.1.1 Brachytherapy Palladium - 103 Iridium - 192 Iodine - 125 Cesium - 131 Other Brachytherapy Products

4.1.2 Alpha Emitters RA - 223 Other Alpha Emitters

4.1.3 Beta Emitters SM - 153 Y - 90 Lu - 117 Re - 186 I - 131 Other Beta Emitters

4.2 Diagnostic Products

4.2.1 PET Radiopharmaceuticals SR - 82/RB - 82 F -18 Other PET Products

4.2.2 SPECT Radiopharmaceuticals TL - 201 I - 123 TC - 99m GA - 67 Other SPECT Products

5 Nuclear Medicine Market, By Procedures

5.1 Central Nervous System

5.2 Gastrointestinal

5.3 Pulmonary

5.4 Therapeutic

5.5 Cardiovascular

5.6 Endocrine

5.7 Genito-Urinary

5.8 PET & PET-CT

5.9 Skeletal

5.10 Other Procedures

6 Nuclear Medicine Market, By Application

6.1 Therapeutic Application

6.1.1 Lymphoma

6.1.2 Thyroid

6.1.3 Endocrine Tumor

6.1.4 Bone Metastasis

6.1.5 Other Therapeutic Application

6.2 Diagnostic Application

6.2.1 Oncology

6.2.2 Cardiology

6.2.3 Neurology

6.2.4 Other Diagnostic Application

7 Nuclear Medicine Market, By Geography

7.1 North America

7.2 Europe

7.3 Asia Pacific

7.4 Middle East

7.5 Latin America

7.6 Rest of the World (RoW)

8 Key Player Activities

8.1 Acquisitions & Mergers

8.2 Agreements, Partnerships, Collaborations and Joint Ventures

8.3 Product Launch & Expansions

8.4 Other Activities

9 Leading Companies

9.1 GE Healthcare

9.2 Siemens Healthcare

9.3 NTP Radioisotopes

9.4 Cardinal Health, Inc.

9.5 Lantheus Holdings

9.6 Triad Isotopes

9.7 Fujifilm Holdings Corporation

9.8 Sigma-Aldrich Corporation.

9.9 Cambridge Isotope Laboratories, Inc.

9.10 Nordion, Inc.

9.11 IBA Group

9.12 Eczacibasi-Monrol

9.13 Bracco S.p.A.

9.14 Medtronic

9.15 Jubilant Pharma LLC

For more information about this report visit https://www.researchandmarkets.com/research/clmcjz/global_nuclear?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181130005184/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Nuclear Medicine and Radiopharmacology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/30/2018 07:27 AM/DISC: 11/30/2018 07:27 AM


Update hourly